Approval · Notice of Compliance 8963 · 2007
FACTIVE: Notice of Compliance 8963
Issued August 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8963
- Date
- August 8, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph - align with the latest approved version of the uspi
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FACTIVE | Not yet assigned | — |
Medicinal ingredients
- GEMIFLOXACIN MESYLATE 320 MG per TAB